StrivePD
Your Parkinson’s Care Companion Webinar Summary
1. Introduction
- Hosted by LSVT Global, featuring Brianna Hood, a clinical specialist at Rune Labs.
2. Overview of StrivePD & Rune Labs
- StrivePD is a digital tool developed by Rune Labs, a San Francisco-based startup, for tracking Parkinson’s symptoms.
- The app enables patients to document and share their unique Parkinson’s experiences with healthcare providers.
3. Development & Patient Involvement
- Originally created by a Parkinson’s patient and later acquired by Rune Labs in 2018.
- A patient advisory board ensures usability and effectiveness by reviewing new features before launch.
4. Features & Data Collection
- Uses Apple Watch (Series 5 and newer) and iPhone to track tremors, dyskinesia, medication adherence, and symptoms.
- Data is automatically recorded and shared with healthcare providers for better clinical decision-making.
- Includes a fall detection feature that alerts emergency services if the user does not respond.
5. Limitations & Apple Exclusivity
- StrivePD is currently only available for Apple devices due to FDA-approved movement disorder tracking.
- Not compatible with Android devices, Fitbits, or Garmin wearables.
6. User Experience & Data Visualization
- Provides a dashboard for tracking symptoms, medication adherence, and exercise.
- Users can manually log symptoms and triggers, including custom inputs.
- Offers an “insight report” summarizing symptoms and trends over time.
7. Clinical Integration & Accessibility
- Healthcare providers can access patient data via a clinician portal.
- No cost for movement disorder specialists to use the platform.
- Patients can print reports for physicians who are not part of StrivePD.
8. Insurance & International Availability
- Currently only available in the U.S. due to regulatory constraints.
- Apple Watches are not covered by insurance, but future coverage is being explored.
9. Potential for Other Conditions
- While validated for idiopathic Parkinson’s, it may also be useful for related disorders like Lewy body dementia and MSA.
- Future studies may compare clinical outcomes between StrivePD users and non-users.
10. Closing Remarks
- The webinar concluded with a Q&A session addressing concerns about device compatibility, data tracking, and clinical integration.
- Participants were encouraged to explore StrivePD for better symptom management and share feedback for future improvements.